Management of renal complications in patients with advanced multiple myeloma

Leukemia and Lymphoma

Volumn 38, Issue 5-6, 2000, Pages 513-519

  Viertel, Achim ^a   Weidmann, Eckhart ^a,b   Ditting, Tilmann ^a   Geiger, Helmut ^a  

^a GOETHE UNIVERSITY   (Germany)

^b UNIVERSITY HOSPITAL FRANKFURT   (Germany)

Author keywords

Chemotherapy; Clinical outcome; Multiple myeloma; Renal impairment; Renal replacement therapy

Indexed keywords

BENDAMUSTINE; CARMUSTINE; CEPHALOSPORIN; CREATININE; CYCLOPHOSPHAMIDE; DEXAMETHASONE; DOXORUBICIN; GENTAMICIN; IMIPENEM; MELPHALAN; PREDNISONE; RECOMBINANT ERYTHROPOIETIN; VINCRISTINE;

ADULT; AGED; ANEMIA; BACTERIAL INFECTION; BONE DESTRUCTION; CHEMOTHERAPY; CHRONIC KIDNEY FAILURE; CLINICAL ARTICLE; CREATININE BLOOD LEVEL; DISEASE COURSE; DIURESIS; FEMALE; HEMODIALYSIS; HUMAN; HUMAN TISSUE; KIDNEY DISEASE; KIDNEY FUNCTION; MALE; MULTIPLE MYELOMA; NEPHROLOGY; OUTCOMES RESEARCH; PLASMAPHERESIS; PRIORITY JOURNAL; RETROSPECTIVE STUDY; REVIEW; SURVIVAL; THROMBOCYTE COUNT;

EID: 0033855757     PISSN: 10428194     EISSN: None     Source Type: Journal    
DOI: 10.3109/10428190009059270     Document Type: Review

References (31)

1. Alexanian R. and Dimopoulos M. (1994) The treatment of multiple myeloma. New England Journal of Medicine, 330, 484-489.
2. Pasquali S., Zucchelli P., Casanova S., Cagnoli L., Confalonieri R., Pozzi C, Banfi G., Lupo A. and Bertani T. (1987) Renal histological lesions and clinical syndroms in multiple myeloma. Clinical Nephrology, 27, 222-228.
3. Rayner H.C., Haynes A.P., Thompson J.R., Russell N. and Fletcher J. (1991) Perspectives in multiple myeloma: Survival, prognostic factors and disease complications in a single centre between 1975 and 1988. Quarterly Journal of Medicine, 290, 517-525.
4. Alpers C.E. (1994) Glomerulopathies of dysproteinemias, abnormal immunoglobulin deposition, and lymphoproliferative disorders. Current Opinion in Nephrology and Hypertension, 3, 349-355.
5. Brown J.H. and Doherty C.C. (1993) Renal replacement therapy in multiple myeloma and systemic amyloidosis. Postgraduate Medicine Journal, 69, 672-678.
6. Ivanyi B. (1993) Development of chronic renal failure in patients with multiple myeloma. Archives of Pathology and Laboratory Medicine, 17, 837-840.
7. Preud'homme J.L., Aucouturier P., Touchard G., Striker L., Khamlichi A.A., Rocca A., Denoroy L. and Cogne M. (1994) Monoclonal immunoglobulin deposition disease (Randall type). Relationship with structural abnormalities of immunoglobulin chains. Kidney International, 46, 965-972.
8. Reusch H.P., Mann J.F., Mihatsch M.J., Siffert W. and Luft F.C. (1995) Light-chain-induced renal tubular acidosis: effect of sodium bicarbonate on sodium-proton exchange. Nephology Dialysis Transplantation, 10, 39-46.
9. Sanders P.W. and Booker B.B. (1992) Pathobiology of cast nephropathy from human Bence Jones proteins. Journal of Clinical Investigation, 89, 630-639.
10. Solomon A., Weiss D.T. and Kattine A.A. (1991) Nephrotoxic potential of Bence Jones proteins. New England Journal of Medicine, 324, 1845-1851.
11. Heilman R.L., Velosa J.A., Holley K.E., Offord K.P. and Kyle R.A. (1992) Long-term follow-up and response to chemotherapy in patients with light-chain deposition disease. American Journal of Kidney Disease, 20, 34-41.
12. Scherberich J.E. and Wolf G. (1994) Disintegration and recovery of kidney membrane proteins: consequence of acute and chronic renal failure. Kidney International, Suppl. 47, 552-557.
13. Montseny J.J., Kleinknecht D., Meyrier A., Vanhille P., Simon P., Pruna A. and Eladari D. (1998) Long-term outcome according to renal histological lesions in 118 patients with monoclonal gammopathies. Nephrology Dialysis Transplantation, 13, 1438-1445.
14. Chauveau D. and Choukroun G. (1996) Bence Jones proteinuria and myeloma kidney. Nephrology Dialysis Transplantation, 11, 413-415.
15. Sharland A., Snowdon L., Joshua D.E., Gibson J. and Tiller D.J. (1997) Hemodialysis: An appropiate therapy in myeloma-induced renal failure. American Journal of Kidney Disease, 30, 786-792.
16. Boccadoro M., Marmont F., Tribalto M., Avvisati G., Andriani A., Barbui T., Cantonetti M., Carontenuto M., Comotti B. and Dammacco F. (1991) Multiple myeloma: VMCP/VBAP alternating combination chemotherapy is not superior to melphalan and prednison even in high-risk patients. Journal of Clinical Oncolology, 3, 444-448.
17. Alexanian R., Barlogie B. and Tucker S. (1990) VAD-based regimens as primary treatment for myeloma. American Journal of Hematology, 33, 86-89.
18. Alexanian R. and Dreicer R. (1984) Chemotherapy for multiple myeloma. Cancer, 53, 583-588.
19. Johnson W.J., Kyle R.A., Pineda A.A., O'Brien P.C. and Holley K.E. (1990) Treatment of renal failure associated with multiple myeloma. Archives of Internal Medicine, 150, 863-869.
20. Pasquali S., Casanova S., Zucchelli A. and Zucchelli P. (1990) Long-term survival of patients with acute and severe renal failure due to multiple myeloma. Clinical Nephrology, 34, 247-254.
21. Mallick N.P. (1989) Dialysis in the managment of the renal failure of myeloma. Quarterly Journal of Medicine, 270, 871-872.
22. Irish A.B., Winearls C.G. and Littlewood T. (1997) Presentation and survival of patients with severe renal failure and myeloma. Quarterly Journal of Medicine, 90, 773-780.
23. van Oers M.H., van Zaanen H.C. and Lokhorst H.M. (1993) Interleukin-6, a new target for therapy in multiple myeloma? Annals of Hematolagy, 66, 219-223.
24. Iggo N. and Parsons V. (1990) Renal disease in multiple myeloma: Current perspectives. Nephron, 56, 229-233.
25. MRC working party on leukaemia in adults. (1984) Analysis and managment of renal failure in fourth MRC myelomatosis trial. British Medical Journal, 288, 1411-1416.
26. Misiani R., Remuzzi G., Bertani T., Licini R., Levoni P., Crippa A. and Mecca G. (1979) Plasmapheresis in the treatment of acute renal failure in multiple myeloma. American Journal of Medicine, 66, 684-688.
27. Ballester O.F. Tummala R., Janssen W.E., Fields K.K., Hiemenz J.W., Goldstein S.C., Perkins J.B., Sullivan D.M., Rosen R., Sackstein R., Zorsky P., Saez R. and Elfenbein G.J. (1997) High-dose chemotherapy and autologous peripheral blood stem cell transplantation in patients with multiple myeloma and renal insufficiency. Bone Marrow Transplantation, 20, 653-656.
28. Torra R., Bladé J., Cases A., Lopez-Pedret J., Montserrat E., Rozman C. and Revert L. (1995) Patients with multiple myeloma requiring long-term dialysis: presenting features, response to therapy, and outcome in a series of 20 cases. British Journal of Haematology, 91, 854-859.
29. Alexanian R., Barlogie B. and Dixon D. (1990) Renal failure in multiple myeloma. Archives of Internal Medicine, 150, 1693-1695.
30. Cosio F.G., Pence T.V., Shapiro F.L. and Kjellstrand C.M. (1981) Severe renal failure in multiple myeloma. Clinical Nephrology, 15, 206-210.
31. Lam K.Y. and Chan K.W. (1993) Unusual findings in a myeloma kidney: A light- and electronmicro-scopic study. Nephron, 65, 133-136.